1. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. (December 2016) Authors: Locati, L.D.; Perrone, F.; Cortelazzi, B.; Bergamini, C.; Bossi, P.; Civelli, E.; Morosi, C.; Lo Vullo, S.; Imbimbo, M.; Quattrone, P.; Dagrada, G.P.; Granata, R.; Resteghini, C.; Mirabile, A.; Alfieri, S.; Orlandi, E.; Mariani, L.; Saibene, G.; Pilotti, S.; Licitra, L. Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma. (March 2019) Authors: van Boxtel, W.; Locati, L.D.; van Engen-van Grunsven, A.C.H.; Bergamini, C.; Jonker, M.A.; Fiets, E.; Cavalieri, S.; Tooten, S.; Bos, E.; Quattrone, P.; Verhaegh, G.W.; Schalken, J.A.; Licitra, L.; van Herpen, C.M.L. Journal: European journal of cancer Issue: Volume 110(2019) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. (July 2018) Authors: Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P.A.; Locati, L.D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients. Issue 3 (June 2017) Authors: Resteghini, C.; Cavalieri, S.; Galbiati, D.; Granata, R.; Alfieri, S.; Bergamini, C.; Bossi, P.; Licitra, L.; Locati, L.D. Journal: Best practice & research Issue: Volume 31:Issue 3(2017) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PH-0043: Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients. (November 2020) Authors: IvaldI, E.; Infante, G.; Facchinetti, N.; Bossi, P.; Iacovelli, N.A.; Cavallo, A.; Ingargiola, R.; Locati, L.D.; Bergamini, C.; Resteghini, C.; Licitra, L.; Platini, F.; Calareso, G.; Fallai, C.; Orlandi, E. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-165 Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract. (March 2019) Authors: Locati, L.D.; Cavalieri, S.; Bergamini, C.; Resteghini, C.; Alfieri, S.; Calareso, G.; Bossi, P.; Quattrone, P.; Granata, R.; Galbiati, D.; Platini, F.; Orlandi, E.; Mariani, L.; Licitra, L. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. (September 2019) Authors: Locati, L.D.; Piovesan, A.; Durante, C.; Bregni, M.; Castagna, M.G.; Zovato, S.; Giusti, M.; Ibrahim, T.; Puxeddu, E.; Fedele, G.; Pellegriti, G.; Rinaldi, G.; Giuffrida, D.; Verderame, F.; Bertolini, F.; Bergamini, C.; Nervo, A.; Grani, G.; Rizzati, S.; Morelli, S. Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗